Post-poliomyelitis syndrome

Muscle and Nerve

Volumn 31, Issue 1, 2005, Pages 6-19

  Trojan, Daria A ^a   Cashman, Neil R ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Electromyography; Pathophysiology; Poliomyelitis; Treatment

Indexed keywords

AMANTADINE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMITRIPTYLINE; ANTIBIOTIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; HUMAN GROWTH HORMONE; LITHIUM; NEUROMUSCULAR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOTHIAZINE DERIVATIVE; PHENYTOIN; PREDNISONE; PYRIDOSTIGMINE; RECOMBINANT SOMATOMEDIN C; STEROID; TETRACYCLINE;

AGING; ANAMNESIS; CELL LOSS; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; DRUG CONTRAINDICATION; ELECTROMYOGRAM; ELECTROPHYSIOLOGY; ERGOMETRY; EXERCISE; FATIGUE; GAIT DISORDER; HEALTH SURVEY; HUMAN; MOTOR UNIT; MUSCLE FATIGUE; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYALGIA; NERVE CELL; NERVE DEGENERATION; NEUROMUSCULAR DISEASE; NEUROPATHOLOGY; ORTHOSIS; PAIN; PATHOPHYSIOLOGY; PHYSIOTHERAPY; POSTPOLIOMYELITIS SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; REVIEW; RISK FACTOR; SWIMMING; TREATMENT OUTCOME;

HUMANS; MUSCLE WEAKNESS; POSTPOLIOMYELITIS SYNDROME;

EID: 11144248588     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20259     Document Type: Review

References (150)

1. Agre JC, Grimby G, Rodriquez AA, Einarsson G, Swiggum ER, Franke TM. A comparison of symptoms between Swedish and American post-polio individuals and assessment of lower limb strength - a four-year cohort study. Scand J Rehabil Med 1995;27:183-192.
2. Agre JC, Rodriquez AA, Franke TM, Swiggum ER, Harmon RL, Curt JT. Low-intensity, alternate-day exercise improves muscle performance without apparent adverse affect in post-polio patients. Am J Phys Med Rehabil 1996;75:50-58.
3. Agre JC, Rodriquez AA, Sperling KB. Symptoms and clinical impressions of patients seen in a post-polio clinic. Arch Phys Med Rehabil 1989;70:367-370.
4. Agre JC, Rodriquez AA, Tafel JA. Late effects of polio: critical review of the literature on neuromuscular function. Arch Phys Med Rehabil 1991;72:923-991.
5. Allen GM, Gandevia SC, Neering IR, Hickie I, Jones R, Middleton J. Muscle performance, voluntary activation and perceived effort in normal subjects and patients with prior poliomyelitis. Brain 1994;117:661-670.
6. Bach JR, Alba A. Pulmonary dysfunction and sleep-disordered breathing as postpolio sequelae: evaluation and management. Orthopedics 1991;14:1329-1337.
7. Bennett RL, Knowlton GC. Overwork weakness in partially denervated skeletal muscle. Clin Orthop 1958;12:22-29.
8. Berlly MH, Strauser WW, Hall KM. Fatigue in post-polio syndrome. Arch Phys Med Rehabil 1991;72:115-118.
9. Blomstrand A, Bake B. Post-polio lung function. Scand J Rehabil Med 1992;24:43-49.
10. Bodian D. Histopathological basis of clinical findings in poliomyelitis. Am J Med 1949;6:563-578.
11. Borg GV. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 1970;21:82-98.
12. Bromberg MB, Waring WP. Neurologically normal patients with suspected postpoliomyelitis syndrome: electromyographic assessment of past denervation. Arch Phys Med Rehabil 1991;72:493-497.
13. Brown S, Patten BM. Post-polio syndrome and amyotrophic lateral sclerosis: a relationship more apparent than real. In: Halstead LS, Wiechers DO, editors. Research and clinical aspects of the late effects of poliomyelitis. White Plains, NY: March of Dimes Birth Defects Foundation; 1987. p 83-98.
14. Bruno RL, Frick NM. Stress and 'type A' behaviour as precipitants of post-polio sequelae: The Felician/Columbia Survey. In: Halstead LS, Weichers DO, editors. Research and clinical aspects of the late effects of poliomyelitis. White Plains, NY: March of Dimes Birth Defects Foundation; 1987. p 145-155.
15. Bruno RL, Frick NM. The psychology of polio as a prelude to post-polio sequelae: behaviour modification and psychotherapy. Orthopedics 1991;14:1185-1193.
16. Bruno RL, Frick NM, Cohen J. Polioencephalitis, stress, and the etiology of post-polio sequelae. Orthopedics 1991;14:1269-1276.
17. Bruno RL, Sapolsky R, Zimmerman JR, Frick NM. Pathophysiology of a central cause of post-polio fatigue. Ann NY Acad Sci 1995;753:257-275.
18. Bruno RL, Zimmerman J, Creange SJ, Lewis T, Molzen T, Frick NM. Bromocriptine in the treatment of post-polio fatigue. Am J Phys Med Rehabil 1996;75:340-347.
19. Buchholz DW, Jones B. Post-polio dysphagia: alarm or caution? Orthopedics 1991;14:1303-1305.
20. Campbell MJ, McComas AJ, Petito F. Physiological changes in ageing muscles. J Neurol Neurosurg Psychiatry 1973;36:174-182.
21. Cashman NR, Maselli R, Wollman RI, Ross R, Simon R, Antel JP. Late denervation in patients with antecedent paralytic poliomyelitis. N Engl J Med 1987;317:7-12.
22. Cashman NR, Maselli R, Wollmann R, Simon R, Heidkamp P, Antel JP. New muscle atrophy as a late symptom of the post-poliomyelitis syndrome. Clin Ecol 1987;5:11-13.
23. Clark K, Dinsmore S, Grafman J, Dalakas MC. A personality profile of patients diagnosed with post-polio syndrome. Neurology 1994;44:1809-1811.
24. Codd MB, Mulder DW, Kurland LT, Beard CM, O'Fallon WM. Poliomyelitis in Rochester, Minnesota, 1935-1955: epidemiology and long-term sequelae. A preliminary report. In: Halstead LS, Wiechers DO, editors. Late effects of poliomyelitis. Miami, FL: Symposia Foundation; 1985. p 121-134.
25. Coers C, Woolf AL. Special pathology of the intramuscular nerves and nerve endings. In: Innervation of muscle. Biopsy study. Springfield, IL: Charles C. Thomas; 1959. p 64-66.
26. Cornil V, Lepine R. Sur un cas de paralysie général spinale antérieure subaigue, sum d'autopsie. Gaz Méd Paris 1875;4:127-129.
27. Da Costa D, Ring A, Dritsa M, Venturini A, LaPierre Y, Trojan DA. Biopsychosocial correlates of depression in multiple sclerosis and post-polio syndrome. Arch Phys Med Rehabil 2002;83:1680-1681.
28. Dalakas MC, Elder G, Hallett M, Ravits J, Baker M, Papadopoulos N, Albrecht P, Sever J. A long-term follow-up study of patients with post-poliomyelitis neuromiiscular symptoms. N Engl J Med 1986;31:959-963.
29. Daube JR, Windebank AJ, Litchy WJ. Electrophysiologic changes in neuromuscular function over five years in polio survivors. Ann NY Acad Sci 1995;753:120-128.
30. Dean E, Ross J. Effect of modified aerobic training on movement energetics in polio survivors. Orthopedics 1991;14:1243-1246.
31. Dean E, Ross J, Road JD, Courtenay L, Madill KJ. Pulmonary function in individuals with a history of poliomyelitis. Chest 1991;100:118-128.
32. Dinsmore S, Dambrosia J, Dalakas MC. A double-blind, placebo-controlled trial of high-dose prednisone for the treatment of post-poliomyelitis syndrome. Ann NY Acad Sci 1995;753:303-313.
33. Drachman DB. The role of acetylcholine as a neurotrophic transmitter. Trophic functions of the neuron. Ann NY Acad Sci 1974;228:160-175.
34. Driscoll BP, Gracco C, Coelho C, Goldstein J, Oshima K, Tierney E, Sasaki CT. Laryngeal function in postpolio patients. Laryngoscope 1995;105:35-41.
35. Einarsson G. Muscle conditioning in late poliomyelitis. Arch Phys Med Rehabil. 1991;72:11-14.
36. Einnarsson G, Grimby G. Strengthening exercise program in post-polio subjects. In: Halstead LS, Weichers DO, editors. Research and clinical aspects of the late effects of poliomyelitis. White Plains, NY: March of Dimes Birth Defects Foundation; 1987. p 275-283.
37. Farbu E, Gilhus NE. Poliomyelitis: long-term consequences for social life. Acta Neurol Scand 1997;96:353-358.
38. Feldman RM. Late effects of poliomyelitis: clinical pathophysiology. In: Halstead LS, Weichers DO, editors. Late effects of poliomyelitis. Miami, FL: Symposia Foundation; 1985. p 109-117.
39. Feldman RM, Soskolne CL. The use of non-fatiguing strengthening exercises in post-polio syndrome. In: Halstead LS, Wiechers DO, editors. Research and clinical aspects of the late effects of poliomyelitis. White Plains, NY: March of Dimes Birth Defects Foundation; 1987. p 335-341.
40. Fillyaw MJ, Badger GJ, Goodwin GD, Bradley WG, Fries TJ, Shukla A. The effects of long-term non-fatiguing resistance exercise in subjects with post-polio syndrome. Orthopedics 1991;14:1253-1256.
41. Finch L, Trojan D, Wilford C, Venturini A. A treadmill walking test in post-polio syndrome patients: preliminary results. Physiother Can 1994;46:117.
42. Finch L, Venturini A, Trojan D, Lemoignan J. Assessment of the health status in post-polio syndrome patients in developing outcomes for a rehabilitation program: a preliminary report. J Int Soc Qual Life Res 1995;4:426.
43. Finkelman R, Munsat T, Andres P, Thornell B, Brussock C. Alterations of strength in post-polio syndrome. In: Munsat TL, editor. Post-polio syndrome. Boston: Butterworth-Heinemann; 1991. p 91-103.
44. Fisher DA. Poliomyelitis: late respiratory complications and management. Orthopedics 1985;88:891-894.
45. Fisher DA. Sleep-disordered breathing as a late effect of poliomyelitis. In: Halstead LS, Wiechers DO, editors. Research and clinical aspects of the late effects of poliomyelitis. White Plains, NY: March of Dimes Birth Defects Foundation; 1987. p 1115-1120.
46. Frick NM. Post-polio sequelae and the psychology of second disability. Orthopedics 1985;8:851-856.
47. Gawne AC, Halstead LS. Post-polio syndrome: pathophysiology and clinical management. Crit Rev Phys Rehabil Med 1995;7:147-188.
48. Gawne AC, Pham BT, Halstead LS. Electrodiagnostic findings in 108 consecutive patients referred to a post-polo clinic. Ann NY Acad Sci 1995;753:383-385.
49. Ghigo E, Goffi S, Arvat E, Nicolosi M, Procopio M, Bellone J, Imperiale E, Mazza E, Baracchi G, Camanni F. Pyridostigmine partially restores the GH responsiveness to GHRH in normal aging. Acta Endocrinol 1990;123:169-174.
50. Grimby G, Einarsson G. Muscle morphology with special reference to muscle strength in post-polio subjects. In: Halstead LS, Wiechers DO, editors. Research and clinical aspects of the late effects of poliomyelitis. White Plains, NY: March of Dimes Birth Defects Foundation; 1987. p 265-274.
51. Grimby G, Hedberg M, Henning GB. Changes in muscle morphology, strength and enzymes in a 4-5 year follow-up of subjects with poliomyelitis sequelae. Scand J Rehabil Med 1994;26:121-130.
52. Grimby G, Stalberg E, Sandberg A, Sunnerhagen K. An eight year longitudinal study of muscle strength, muscle fiber size and dynamic electromyogram in individuals with late polio. Muscle Nerve 1998;21:1428-1437.
53. Grimby G, Thoren-Jonsson AL. Disability in poliomyelitis sequelae. Phys Ther 1994;74:415-424.
54. Gupta KL, Shetty KR, Agre JC, Cuisinier MC, Rudman IW, Rudman D. Human growth hormone effect on serum IGF-I and muscle function in poliomyelitis survivors. Arch Phys Med Rehabil 1994;75:889-894.
55. Halstead LS. Post-polio syndrome: definition of an elusive concept. In: Munsat TL, editor. Post-polio syndrome. Boston: Butterworth-Heinemann; 1991. p 23-38.
56. Halstead LS, Rossi CD. Post-polio syndrome: clinical experience with 132 consecutive outpatients. In: Halstead LS, Wiechers DO, editors. Research and clinical aspects of the late effects of poliomyelitis. White Plains, NY: March of Dimes Birth Defects Foundation; 1987. p 13-26.
57. Halstead LS, Silver JK. Nonparalytic polio and postpolio syndrome. Am J Phys Med Rehabil 2000;79:13-18.
58. Halstead LS, Wiechers DO, Rossi CD. Late effects of poliomyelitis: a national survey. In: Halstead LS, Wiechers DO, editors. Late effects of poliomyelitis. Miami, FL: Symposia Foundation; 1985. p 11-31.
59. Hazendonk KM, Crowe SF. A neuropsychological study of the postpolio syndrome: support for depression without neuropsychological impairment. Neuropsychiatry Neuropsychol Behav Neurol 2000;13:112-118.
60. Hodes R. Electromyographic study of defects of neuromuscular transmission in human poliomyelitis. Arch Neurol Psychiatry 1948;60:457-473.
61. John TJ. The final stages of the global eradication of polio. N Engl J Med 2000;343:806-807.
62. Jones B, Buchholz DW, Ravich WJ, Donner MW. Swallowing dysfunction in the postpolio syndrome: a cinefluorographic study. AJR 1992;153:283-286.
63. Jones DR, Speier J, Canine K, Owen R, Stull GA. Cardiorespiratory responses to aerobic training by patients with post-poliomyelitis sequelae. JAMA 1989;261:3255-3258.
64. Jubelt B, Agre JC. Characteristics and management of postpolio syndrome. JAMA
65. Jubelt B, Cashman NR. Neurological manifestations of the post-polio syndrome. CRC Crit Rev Neurobiol 1987;3:199-220.
66. Kaminski HJ, Tresser N, Hogan RE, Martin E. Spinal cord histopathology in long-term survivors of poliomyelitis. Muscle Nerve 1995;18:1208-1209.
67. Kemp BJ, Adams BM, Campbell ML. Depression and life satisfaction in aging polio survivors versus age-matched controls: relation to postpolio syndrome, family functioning, and attitude toward disability. Arch Phys Med Rehabil 1997;78:187-192.
68. Kling C, Persson A, Gardulf A. The health-related quality of life of patients suffering from the late effects of polio (postpolio). J Adv Nursing 2000;32:164-173.
69. Klingman J, Chu H, Corgiat M, Perry J. Functional recovery. A major risk factor for the development of postpoliomyelitis muscular atrophy. Arch Neurol 1988;45:645-647.
70. Knowlton GC, Bennett RL. Overwork. Arch Phys Med Rehabil 1957;38:18-20. 2000;284:412-414.
71. Knowlton GC, Bennett RL. Overwork. Arch Phys Med Rehabil 1957;38:18-20. 2000;284:412-414.
72. Kohl SJ. Emotional responses to the late effects of poliomyelitis. In: Halstead LS, Wiechers DO, editors. Research and clinical aspects of the late effects of poliomyelitis. White Plains, NY: March of Dimes Birth Defects Foundation; 1987. p 135-143.
73. Kriz JL, Jones DR, Speier JL, Owen RR, Serfass RC. Cardiorespiratory responses to upper extremity aerobic training by postpolio subjects. Arch Phys Med Rehabil 1992;73:49-54.
74. Lange DL, Smith T, Lovelace RE. Postpolio muscular atrophy: diagnostic utility of macroelectromyography. Arch Neurol 1989;46:502-506.
75. Leon-Monzon ME, Dalakas MC. Detection of poliovirus antibodies and poliovirus genome in patients with the postpolio syndrome. Ann NY Acad Sci 1995;753:208-218.
76. Leparc-Goffart I, Julien J, Fuchs F, Janatova I, Aymard M, Kopecka H. Evidence of presence of poliovirus genomic sequences in cerebrospinal fluid from patients with postpolio syndrome. J Clin Microbiol 1996;34:2023-2026.
77. Liu S, Modell JH. Anesthetic management for patients with postpolio syndrome receiving electroconvulsive therapy. Anesthesiology 2001;95:799-801.
78. Lonnberg F, Madsen M. Late onset polio sequelae in Denmark. Scand J Rehabil Med 1993;28(suppl):17-23.
79. Luciano CA, Sivakumar K, Spector SA, Dalakas MC. Electrophysiologic and histologic studies in clinically unaffected muscles of patients with prior paralytic polimyelitis. Muscle Nerve 1996;19:1413-1420.
80. March of Dimes. Post-polio syndrome: identifying best practices in diagnosis and care. White Plains, NY: March of Dimes Birth Defects Foundation; 2001 (www.modimes.org).
81. Maselli RA, Cashman NR, Wollman RL, Salazar-Grueso EF, Roos R. Neuromuscular transmission as a function of motor unit size in patients with prior poliomyelitis. Muscle Nerve 1992;15:648-655.
82. Maselli RA, Wollman R, Roos R. Function and utrastructure of the neuromuscular junction in post-polio syndrome. Ann NY Acad Sci 1995;753:129-137.
83. McComas AJ, Quartly C, Griggs RC. Early and late losses of motor units after poliomyelitis. Brain 1997;120:1415-1421.
84. McComas AJ, Upton ARM, Sica REP. Motoneurone disease and ageing. Lancet 1973;2:1477-1480.
85. Melchers W, de Visser M, Jongen P, van Loon A, Nibbeling R, Oostvogel P, Willemse D, Galama J. The postpolio syndrome: no evidence for poliovirus persistence. Ann Neurol 1992:32:728-732.
86. Midgren B. Lung function and clinical outcome in postpolio patients: a prospective cohort study during 11 years. Eur Respir J 1997;10:146-149.
87. Miller RG, Gelinas DF, Kent-Braun J, Dobbins T, Dao H, Dalakas M. The effect of recombinant insulin-like growth factor I (rhIGF-I) on exercise-induced fatigue and recovery in patients with post-polio syndrome. Neurology 1997;48: A217.
88. Muir P, Nicholson F, Sharief MK, Thompson EJ, Cairns NJ, Lantos P, Spencer GT, Kaminski HJ, Banatvala JE. Evidence for persistent enterovirus infection of the central nervous system in patients with previous paralytic poliomyelitis. Ann NY Acad Sci 1995;753:219-232.
89. Muller EA. Influence of training and of inactivity on muscle strength. Arch Phys Med Rehabil 1970;51:449-462.
90. Muller EE, Locatelli V, Ghigo E, Cella SG, Loche S, Pintor C, Camanni F. Involvement of brain catecholamines and acetylcholine in growth hormone deficiency states: pathophysiological, diagnostic, and therapeutic implications. Drugs 1991;41:161-177.
91. Munin MC, Jaweed MM, Staas WE Jr, Satinsky AR, Gutlerez G, Herbison GJ. Postpoliomyelitis muscle weakness: a prospective study of quadriceps strength. Arch Phys Med Rehabil 1991;72:729-733.
92. Murialdo G, Fonzi S, Torre F, Costelli P, Solinas G, Tosca P, Di Paolo E, Porro S, Zerbi F, Polleri A. Effects of pyridostigmine, corticotropin-releasing hormone and growth hormone-releasing hormone on the pituitary-adrenal axis and on growth hormone secretion in dementia. Neuropsychobiology 1993;28:177-183.
93. Nollet F, Beelen A, Twisk JW, Lankhorst GJ, de Visser M. Perceived health and physical functioning in postpoliomyelitis syndrome: a 6-year prospective follow-up study. Arch Phys Med Rehabil 2003;84:1048-1056.
94. Nollet F, Horemans HLD, Beelen A, Drost G, Zwarts MJ, deVisser M, Lankhorst GJ. Pyridostigmine in postpolio syndrome: a randomized double-blinded trial. Neurology 2002;58(suppl 2):199-200.
95. Parsons PE. Letter. N Engl J Med 1991;325:1108.
96. Paul JR. History of poliomyelitis. New Haven, CT: Yale University Press; 1971. p 1-36.
97. Peach PE. Overwork weakness with evidence of muscle damage in a patient with residual paralysis from polio. Arch Phys Med Rehabil 1990;71:248-250.
98. Peach PE, Olejnik S. Post-polio sequelae: effect of treatment and noncompliance on post-polio sequelae. Orthopedics 1991;14:1199-1203.
99. Perry J, Barnes G, Gronley JK. The post-polio syndrome: an overuse phenomenon. Clin Orthop Rel Res 1988;233:145-162.
100. Perry J, Fontaine JD, Mulroy S. Findings in post-poliomyelitis syndrome. J Bone Joint Surg 1995;77-A:1148-1153.
101. Pezeshkpour GH, Dalakas MC. Pathology of spinal cord in post-poliomyelitis muscular atrophy. In: Halstead LS, Wiechers DO, editors. Research and clinical aspects of the late effects of poliomyelitis. White Plains, NY: March of Dimes Birth Defects Foundation; 1987. p 229-236.
102. Post-Polio Task Force. Post-polio syndrome update. Biosci Rep 1997;5.
103. Prins JH, Hartung H, Merritt DJ, Blanq RJ, Goebert DA. Effect of aquatic exercise training in persons with poliomyelitis disability. Sports Med Training Rehabil 1994;5:29-39.
104. Ramlow J, Alexander M, LaPorte R, Kaufman C, Kuller L. Epidemiology of the post-polio syndrome. Am J Epidemiol 1992;136:769-786.
105. Rao U, Shetty KP, Mattson DE, Rudman IW, Rudman D. Prevalence of low plasma 1GF-1 in poliomyelitis survivors. J Am Geriatr Soc 1993;41:697-702.
106. Raymond F. Paralysie essentielle de l'enfance, atrophie musculaire consécutive. Gaz Méd Paris 1875;4:225-226.
107. Rodriquez AA, Agre JC. Electrophysiologic study of the quadriceps muscle during fatiguing exercise and recovery: a comparison of symptomatic and asymptomatic postpolio patients and controls. Arch Phys Med Rehabil 1991;72:993-997.
108. Rodriquez AA, Agre JC. Physiologic parameters and perceived exertion with local muscle fatigue in postpolio subjects. Arch Phys Med Rehabil. 1991;72:305-308.
109. Salazar-Grueso EF, Grimaldi LME, Roos RP, Variakojis R, Jubelt B, Cashman NR. Isoelectric focusing studies of serum and cerebrospinal fluid in patients with antecedent poliomyelitis. Ann Neurol 1989;26:709-713.
110. Sandberg A, Hansson B, Stalberg E. Comparison between concentric needle EMG and macro EMG in patients with a history of polio. Clin Neurophysiol 1999;110:1900-1908.
111. Schanke A-K, Stanghelle JK. Fatigue in polio survivors. Spinal Cord 2001;39:243-251.
112. Seizert BP, Speier JL, Canine JK. Pyridostigmine effect on strength, endurance, and fatigue in post-polio patients. Arch Phys Med Rehabil 1994;75:1049.
113. Sharief MK, Hentges R, Ciardi M. Intrathecal immune response in patients with the post-polio syndrome. N Engl J Med 1991;325:749-755.
114. Smith LK, McDermott K. Pain in post-poliomyelitis: addressing causes versus treating effects. In: Halstead LS, Wiechers DO, editors. Research and clinical aspects of the late effects of poliomyelitis. White Plains, NY: March of Dimes Birth Defects Foundation; 1987. p 121-134.
115. Sonies BC. Long-term effects of post-polio on oral-motor and swallowing function. In: Halstead LS, Grimby G, editors. Post-polio syndrome. Philadelphia: Hanley & Belfus; 1995. p 125-140.
116. Sonies BC, Dalakas MC. Dysphagia in patients with the postpolio syndrome. N Engl J Med 1991;324:1162-1167.
117. Speier JL, Owen RR, Knapp M, Canine JK. Occurrence of post-polio sequelae in an epidemic population. In: Halstead LS, Wiechers DO, editors. Research and clinical aspects of the late effects of poliomyelitis. White Plains, NY: March of Dimes Birth Defects Foundation; 1987. p 39-48.
118. Stalberg E, Grimby G. Dynamic electromyography and muscle biopsy changes in a 4-year follow-up: study of patients with a history of polio. Muscle Nerve 1995;18:699-707.
119. Stalberg E, Thiele B. Motor unit fibre density in the extensor digitorum communis muscle. J Neurol Neurosurg Psychiatry 1975;38:874-880.
120. Stein DP, Dambrosia J, Dalakas MC. A double-blind, placebo-controlled trial of high-dose prednisone for the treatment of post-poliomyelitis syndrome. Ann NY Acad Sci 1995;753:296-302.
121. Tate DG, Forchheimer M, Kirsch N, Maynard F, Roller A. Prevalence and associated features of depression and psychological distress in polio survivors. Arch Phys Med Rehabil. 1993;74:1056-1060.
122. Thorenjonsson A-L, Grimby G. Ability and perceived difficulty in daily activities in people with poliomyelitis sequelae. J Rehabil Med 2001;33:4-11.
123. Tomlinson BE, Irving D. The number of limb motor neurons in the human lumbosacral cord throughout life. J Neurol Sci 1977;34:213-219.
124. Trasforini G, Margutti A, Vergnani L, Ambrosio MR, Valentini A, Rossi R, Portaluppi F, Uberti ECD. Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man. J Clin Endocrinol Metab 1994;78:763-766.
125. Trojan DA. A case-control study of risk factors for post-poliomyelitis syndrome. A Master's thesis, Department of Epidemiology and Biostatistics, McGill University, Montreal, 1992.
126. Trojan DA, Cashman NR. Fibromyalgia is common in a postpoliomyelitis clinic. Arch Neurol 1995;52:620-624.
127. Trojan DA, Cashman NR. An open trial of pyridostigmine in a post-poliomyelitis clinic. Can J Neurol Sci 1995;22:223-227.
128. Trojan DA, Cashman NR. Current trends in post-poliomyelitis syndrome. New York: Milestone Medical Communications; 1996. p 27-30.
129. Trojan DA, Cashman NR. Pathophysiology and diagnosis of post-polio syndrome. Neurorehabilitation 1997;8:83-92.
130. Trojan DA, Cashman NR, Shapiro S, Tansey C, Esdaile JM. Predictive factors for post-poliomyelitis syndrome. Arch Phys Med Rehabil 1994;75:770-777.
131. Trojan DA, Collet J-P, Pollak MN, Shapiro S, Jubelt B, Miller RG, Agre JC, Munsat TL, Hollander D, Tandan R, Robinson A, Finch L, Ducruet T, Cashman NR. Serum IGF-I does not correlate positively with isometric strength, fatigue, and quality of life in post-polio syndrome. J Neurol Sci 2001;182:107-115.
132. Trojan DA, Collet J-P, Shapiro S, Jubelt B, Miller RG, Agre JC, Munsat TL, Hollander D, Tandan R, Granger C, Robinson A, Finch L, Ducruet T, Cashman NR. A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology 1999;53:1225-1233.
133. Trojan DA, Finch L. Management of post-polio syndrome. Neurorehabilitation 1997;8:93-105.
134. Trojan DA, Gendron D, Cashman NR. Electrophysiology and electrodiagnosis of the post-polio motor unit. Orthopedics 1991;14:1353-1361.
135. Trojan DA, Gendron D, Cashman NR. Anticholinesterase-responsive neuromuscular junction transmission defects in post-poliomyelitis fatigue. J Neurol Sci 1993;114:170-177.
136. Trojan DA, Gendron D, Cashman NR. Stimulation frequency-dependent neuromuscular junction transmission defects in patients with prior paralytic poliomyelitis. J Neurol Sci 1993;118:150-157.
137. Trojan DA, Gendron D, Cashman NR. Macroelectromyography and fiber density in postpoliomyelitis syndrome. Arch Phys Med Rehabil 1994;75:1026.
138. Trojan DA, Shapiro S, Cashman NR, Finch L, Ducruet T, Robinson A, Collet J-P. Isometric strength, fatigue, and quality of life over time in post-poliomyelitis syndrome. Neurology 2003;60(suppl 1):A73.
139. Ulfberg J, Jonsson R, Ekeroth G. Sleep apnea syndrome among poliomyelitis survivors. Neurology 1997;49:1189.
140. Vasiliadis H-M, Collet J-P, Shapiro S, Venturini A, Trojan DA. Predictive factors and correlates for pain in post-poliomyelitis syndrome. Arch Phys Med Rehabil 2002;83:1109-1115.
141. Waring WP, Maynard F, Grady W, Grady R, Boyles C. Influence of appropriate lower extremity orthotic management on ambulation, pain, and fatigue in a postpolio population. Arch Phys Med Rehabil 1989;70:371-375.
142. Waring WP, McLaurin TM. Correlation of creatine kinase and gait measurement in the postpolio population: a corrected version. Arch Phys Med Rehabil 1992;73:447-450.
143. Werner RA, Waring W, Maynard F. Osteoarthritis of the hand and wrist in the post poliomyelitis population. Arch Phys Med Rehabil 1992;73:1069-1072.
144. Wiechers DO, Hubbell SL. Late changes in the motor unit after acute poliomyelitis. Muscle Nerve 1981;4:524-528.
145. Wiechers DO. New concepts of the reinnervated motor unit revealed by vaccine-associated poliomyelitis. Muscle Nerve 1988;11:356-364.
146. Willen C, Grimby G. Pain, physical activity, and disability in individuals with late effects of polio. Arch Phys Med Rehabil 1998;79:915-919.
147. Windebank AJ, Daube JR, Litchy WJ, Codd M, Chao EYS, Kurland LT, Iverson R. Late sequelae of paralytic poliomyelitis in Olmsted County, Minnesota. In: Halstead LS, Wiechers DO, editors. Research and clinical aspects of the late effects of poliomyelitis. White Plains, NY: March of Dimes Birth Defects Foundation; 1987. p 27-38.
148. Windebank AJ, Litchy WJ, Daube JR, Iverson RA. Lack of progression of neurologic deficit in survivors of paralytic polio. Neurology 1996;46:80-84.
149. Windebank AJ, Litchy WJ, Daube JR, Kurland LT, Codd MB, Iverson R. Late effects of paralytic poliomyelitis in Olmsted County, Minnesota. Neurology 1991;41:501-507.
150. Wolfe F, Smythe HA, Yunus MB. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990;33:160-172.